Over the past eight months, Theranos has been in the news for all the wrong reasons. The medical company claimed to be able to deliver accurate test results from just a single drop of blood, but it was discovered that it voided results from tests conducted in 2014 and 2015. Last month, Forbes revised founder Elizabeth Holmes’ net worth from $4.5 billion to zero. Now, Centers for Medicare & Medicaid Services (CMS) has imposed sanctions on Theranos’ Newark, California laboratory and CEO Holmes following its 2015 survey. The Newark facility will have its Clinical Laboratory Improvement Amendments (CLIA) certificate revoked, and…

This story continues at The Next Web